Bioequivalence and Bioavailability Forum 05:55 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Sample size determination for William Design [Power / Sample Size]

posted by Irene_I - Indonesia, 2018-07-04 10:27  - Posting: # 19016
Views: 576

Dear All,

I would like to ask about sample size determination for conducting William Design (3 treatment - 3 period - 6 sequence) bioequivalence. We would like to compare two test product with one reference product. Based on available literature, the drug product we would like to compare has about 19.03% intra-subject CV for AUC. Usually, we calculate the sample size by intra-subject CV from the previous study and referred to Diletti table (E Diletti, D Hauschke, and VW Steinijans, Sample size determination for bioequivalence assessment by means of confidence intervals). Is that also applicable for the 3x3x6 study? Or, is there any other method to determine sample size for william design?

I would be very thankful for your help.

Thank you very much.

Regards,


Irene I


Edit: Category changed; see also this post #1[Helmut]

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,698 posts in 3,983 threads, 1,237 registered users;
online 15 (0 registered, 15 guests [including 8 identified bots]).

When puzzled, it never hurts to read the primary documents –
a rather simple and self-evident principle that has, nonetheless,
completely disappeared from large sectors
of the American experience.    Stephen Jay Gould

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed